| [1] | MAYLE A, YANG L, RODRIGUEZ B, et al.Dnmt3a loss predisposes murine hematopoietic stem cells to malignant transformation[J].Blood, 2015, 125(4):629. |
| [2] | YANG L, RAU R, GOODELL MA.DNMT3A in haematological malignancies[J].Nat Rev Cancer, 2015, 15(3):152. |
| [3] | RUSSLER-GERMAIN DA, SPENCER DH, YOUNG MA, et al.The R882H DNMT3A mutation associated with AML dominantly inhibits wild-type DNMT3A by blocking its ability to form active tetramers[J].Cancer Cell, 2014, 25(4):442. |
| [4] | JOST E, LIN Q, WEIDNER CI, et al.Epimutations mimic genomic mutations of DNMT3A in acute myeloid leukemia[J].Leukemia, 2014, 28(6):1227. |
| [5] | THAKRAL G, VIERKOETTER K, NAMIKI S, et al.AML multi-gene panel testing:A review and comparison of two gene panels[J].Pathol Res Pract, 2016, 212(5):372. |
| [6] | ZARE-ABDOLLAHI D, SAFARI S, MOVAFAGH A, et al.A mutational and expressional analysis of DNMT3A in acute myeloid leukemia cytogenetic subgroups[J].Hematology, 2015, 20(7):397. |
| [7] | HOU HA, KUO YY, LIU CY, et al.DNMT3A mutations in acute myeloid leukemia:stability during disease evolution and clinical implications[J].Blood, 2012, 119(2):559. |
| [8] | EL GHANNAM D, TAALAB MM, GHAZY HF, et al.DNMT3A R882 mutations in patients with cytogenetically normal acute myeloid leukemia and myelodysplastic syndrome[J].Blood Cells Mol Dis, 2014, 53(1/2):61. |
| [9] | 章梁君, 蒋能刚, 周娟, 等.急性髓细胞白血病DNMT3A突变的免疫表型特征分型[J].临床检验杂志, 2014, 32(8):572. |
| [10] | AHN JS, KIM HJ, KIM YK, et al.DNMT3A R882 mutation with FLT3-ITD positivity is an extremely poor prognostic factor in patients with normal-karyotype acute myeloid leukemia after allogeneic hematopoietic cell transplantation[J].Biol Blood Marrow Transplant, 2016, 22(1):61. |
| [11] | XU Y, SUN Y, SHEN H, et al.Allogeneic hematopoietic stem cell transplantation could improve survival of cytogenetically normal adult acute myeloid leukemia patients with DNMT3A mutations[J].Am J Hematol, 2015, 90(11):992. |
| [12] | IBRAHEM L, MAHFOUZ R, ELHELW L, et al.Prognostic significance of DNMT3A mutations in patients with acute myeloid leukemia[J].Blood Cells Mol Dis, 2015, 54(1):84. |
| [13] | IM AP, SEHGAL AR, CARROLL MP, et al.DNMT3A and IDH mutations in acute myeloid leukemia and other myeloid malignancies:associations with prognosis and potential treatment strategies[J].Leukemia, 2014, 28(9):1774. |